RSS
Calculus Capital
Private equity firm invests in Cambridge biotech
A private equity firm, Calculus Capital, has invested £2.5 million in the Cambridge-based biotech company, Axol Bioscience. more
© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.
The essential information source for professionals involved in the formulation, development, manufacturing and supply of drugs and medicines in the pharmaceutical and biopharmaceutical industry.
SUBSCRIBE NOW!